The association of tea consumption with ovarian cancer risk: A metaanalysis

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 6, 2007, Pages 594.e1-594.e6

  Zhou, Bo ^a   Yang, Li ^a   Wang, Liansheng ^a   Shi, Yanping ^b   Zhu, Huaijun ^a   Tang, Naping ^a   Wang, Bin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

metaanalysis; ovarian cancer; tea consumption

Indexed keywords

ARTICLE; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; COCHRANE LIBRARY; COHORT ANALYSIS; DIET; EMBASE; HUMAN; MEDLINE; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW; TEA;

EID: 36448935704     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.05.027     Document Type: Article

References (27)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Poveda A. Ovarian cancer: is the news good enough?. Int J Gynecol Cancer 15 suppl 3 (2005) 298-306
3. Zhu H., Yang L., Zhou B., Yu R., Tang N., and Wang B. Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study. Carcinogenesis 27 (2006) 2491-2496
4. Wang B. Major causes of death in China. N Engl J Med 354 (2006) 874-876
5. Blumberg J. Introduction to the proceedings of the Third International Scientific Symposium on Tea and Human Health: Role of Flavonoids in the Diet. J Nutr 133 (2003) 3244-3246
6. Ravindranath M.H., Saravanan T.S., Monteclaro C.C., et al. Epicatechins purified from green tea (Camellia sinensis) differentially suppress growth of gender-dependent human cancer cell lines. Evid Based Complement Alternat Med 3 (2006) 237-247
7. Zhang M., Lee A.H., Binns C.W., and Xie X. Green tea consumption enhances survival of epithelial ovarian cancer. Int J Cancer 112 (2004) 465-469
8. Binns C.W., Zhang M., Lee A.H., and Xie C.X. Green tea consumption enhances survival of epithelial ovarian cancer patients. Asia Pac J Clin Nutr 13 Suppl (2004) S116
9. Byers T., Marshall J., Graham S., Mettlin C., and Swanson M. A case-control study of dietary and nondietary factors in ovarian cancer. J Natl Cancer Inst 71 (1983) 681-686
10. Zheng W., Doyle T.J., Kushi L.H., Sellers T.A., Hong C.P., and Folson A.R. Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 144 (1996) 175-182
11. Larsson S.C., and Wolk A. Tea consumption and ovarian cancer risk in a population-based cohort. Arch Intern Med 165 (2005) 2683-2686
12. Miller D.R., Rosenberg L., Kaufman D.W., et al. Epithelial ovarian cancer and coffee drinking. Int J Epidemiol 16 (1987) 13-17
13. La Vecchia C., Negri E., Franceschi S., D'Avanzo B., and Boyle P. Tea consumption and cancer risk. Nutr Cancer 17 (1992) 27-31
14. Kuper H., Titus-Ernstoff L., Harlow B.L., and Cramer D.W. Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer. Int J Cancer 88 (2000) 313-318
15. Tavani A., Gallus S., Dal Maso L., et al. Coffee and alcohol intake and risk of ovarian cancer: an Italian case-control study. Nutr Cancer 39 (2001) 29-34
16. Zhang M., Binns C.W., and Lee A.H. Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol Biomarkers Prev 11 (2002) 713-718
17. Goodman M.T., Tung K.H., McDuffie K., Wilkens L.R., and Donlon T.A. Association of caffeine intake and CYP1A2 genotype with ovarian cancer. Nutr Cancer 46 (2003) 23-29
18. Jordan S.J., Purdie D.M., Green A.C., and Webb P.M. Coffee, tea and caffeine and risk of epithelial ovarian cancer. Cancer Causes Control 15 (2004) 359-365
19. Hong X., Yu R.B., Sun N.X., Wang B., Xu Y.C., and Wu G.L. Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis. World J Gastroenterol 11 (2005) 7302-7307
20. Petitti D.B. Approaches to heterogeneity in meta-analysis. Stat Med 20 (2001) 3625-3633
21. Sterne J.A., and Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54 (2001) 1046-1055
22. Wu A.H., and Yu M.C. Tea, hormone-related cancers and endogenous hormone levels. Mol Nutr Food Res 50 (2006) 160-169
23. Lee A.H., Fraser M.L., and Binns C.W. Possible role for green tea in ovarian cancer prevention. Future Oncol 1 (2005) 771-777
24. Huh S.W., Bae S.M., Kim Y.W., et al. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gynecol Oncol 94 (2004) 760-768
25. Jung Y.D., Kim M.S., Shin B.A., et al. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 84 (2001) 844-850
26. Zhang G., Miura Y., and Yagasaki K. Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity. Cancer Lett 159 (2000) 169-173
27. Saha P., Banerjee S., Ganguly C., Manna S., Panda C.K., and Das S. Black tea extract can modulate protein expression of H-ras, c-Myc, p53, and Bcl-2 genes during pulmonary hyperplasia, dysplasia, and carcinoma in situ. J Environ Pathol Toxicol Oncol 24 (2005) 211-224